It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Sleep-wake driven changes in non-rapid-eye-movement sleep (NREM) sleep (NREMS) EEG delta (δ-)power are widely used as proxy for a sleep homeostatic process. Here, we noted frequency increases in δ-waves in sleep-deprived mice, prompting us to re-evaluate how slow-wave characteristics relate to prior sleep-wake history. We identified two classes of δ-waves; one responding to sleep deprivation with high initial power and fast, discontinuous decay during recovery sleep (δ2) and another unrelated to time-spent-awake with slow, linear decay (δ1). Reanalysis of previously published datasets demonstrates that δ-band heterogeneity after sleep deprivation is also present in human subjects. Similar to sleep deprivation, silencing of centromedial thalamus neurons boosted subsequent δ2-waves, specifically. δ2-dynamics paralleled that of temperature, muscle tone, heart rate, and neuronal ON-/OFF-state lengths, all reverting to characteristic NREMS levels within the first recovery hour. Thus, prolonged waking seems to necessitate a physiological recalibration before typical NREMS can be reinstated.
Changes in EEG delta-activity are widely used as proxy of sleep propensity. Here the authors demonstrate in mice and humans the presence of two types of delta-waves, only one of which reports on prior sleep-wake history with dynamics denoting a wake-inertia process accompanying deepest non-rapid-eye-movement sleep (NREM) sleep.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Lausanne, Center for Integrative Genomics, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204)
2 Inselspital University Hospital Bern, Department of Neurology, Bern, Switzerland (GRID:grid.411656.1) (ISNI:0000 0004 0479 0855); University of Zürich, Department of Veterinary Anesthesia, Zürich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
3 Université de Montréal, Department of Neuroscience, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357)
4 University of Zürich, Institute of Pharmacology and Toxicology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); University of Zürich, Sleep & Health Zürich, Zürich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
5 Inselspital University Hospital Bern, Department of Neurology, Bern, Switzerland (GRID:grid.411656.1) (ISNI:0000 0004 0479 0855); University of Bern, Department of Biomedical Research, Bern, Switzerland (GRID:grid.5734.5) (ISNI:0000 0001 0726 5157)